97 related articles for article (PubMed ID: 20138768)
1. Synthesis and evaluation of 1,4-diphenylbutadiene derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) production.
Miyazaki H; Sai H; Ohmizu H; Murakami J; Ohtani A; Ogiku T
Bioorg Med Chem; 2010 Mar; 18(5):1968-79. PubMed ID: 20138768
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and evaluation of orally active inhibitors of plasminogen activator inhibitor-1 (PAI-1) production.
Miyazaki H; Ogiku T; Sai H; Ohmizu H; Murakami J; Ohtani A
Bioorg Med Chem Lett; 2008 Dec; 18(24):6419-22. PubMed ID: 18993062
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of pyrrolin-2-one derivatives synthesized by a new practical method as inhibitors of plasminogen activator inhibitor-1 (PAI-1).
Miyazaki H; Miyake T; Terakawa Y; Ohmizu H; Ogiku T; Ohtani A
Bioorg Med Chem Lett; 2010 Jan; 20(2):546-8. PubMed ID: 19969458
[TBL] [Abstract][Full Text] [Related]
4. Tiplaxtinin, a novel, orally efficacious inhibitor of plasminogen activator inhibitor-1: design, synthesis, and preclinical characterization.
Elokdah H; Abou-Gharbia M; Hennan JK; McFarlane G; Mugford CP; Krishnamurthy G; Crandall DL
J Med Chem; 2004 Jul; 47(14):3491-4. PubMed ID: 15214776
[TBL] [Abstract][Full Text] [Related]
5. Identification of orally bioavailable, non-amidine inhibitors of Urokinase Plasminogen Activator (uPA).
West CW; Adler M; Arnaiz D; Chen D; Chu K; Gualtieri G; Ho E; Huwe C; Light D; Phillips G; Pulk R; Sukovich D; Whitlow M; Yuan S; Bryant J
Bioorg Med Chem Lett; 2009 Oct; 19(19):5712-5. PubMed ID: 19703768
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of pyrrolin-2-one compounds, a series of plasminogen activator inhibitor-1 inhibitors.
Miyazaki H; Ogiku T; Sai H; Moritani Y; Ohtani A; Ohmizu H
Chem Pharm Bull (Tokyo); 2009 Sep; 57(9):979-85. PubMed ID: 19721260
[TBL] [Abstract][Full Text] [Related]
7. In vitro PAI-1 inhibitory activity of oxalamide derivatives.
Jain MR; Shetty S; Chakrabarti G; Pandya V; Sharma A; Parmar B; Srivastava S; Raviya M; Soni H; Patel PR
Eur J Med Chem; 2008 Apr; 43(4):880-4. PubMed ID: 17664030
[TBL] [Abstract][Full Text] [Related]
8. A novel inhibitor of plasminogen activator inhibitor-1 provides antithrombotic benefits devoid of bleeding effect in nonhuman primates.
Izuhara Y; Yamaoka N; Kodama H; Dan T; Takizawa S; Hirayama N; Meguro K; van Ypersele de Strihou C; Miyata T
J Cereb Blood Flow Metab; 2010 May; 30(5):904-12. PubMed ID: 20087372
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position.
Tucker TJ; Brady SF; Lumma WC; Lewis SD; Gardell SJ; Naylor-Olsen AM; Yan Y; Sisko JT; Stauffer KJ; Lucas BJ; Lynch JJ; Cook JJ; Stranieri MT; Holahan MA; Lyle EA; Baskin EP; Chen IW; Dancheck KB; Krueger JA; Cooper CM; Vacca JP
J Med Chem; 1998 Aug; 41(17):3210-9. PubMed ID: 9703466
[TBL] [Abstract][Full Text] [Related]
10. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity studies of cyclic ketone inhibitors of the serine protease plasmin: design, synthesis, and biological activity.
Xue F; Seto CT
Bioorg Med Chem; 2006 Dec; 14(24):8467-87. PubMed ID: 16971130
[TBL] [Abstract][Full Text] [Related]
12. Increased plasminogen activator inhibitor-1/tissue type plasminogen activator ratio in oral submucous fibrosis.
Yang SF; Hsieh YS; Tsai CH; Chen YJ; Chang YC
Oral Dis; 2007 Mar; 13(2):234-8. PubMed ID: 17305628
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of the proteinase specificity in wild-type and stabilized plasminogen activator inhibitor-1: evidence for contribution of intramolecular flexibility.
De Taeye B; Gils A; Vleugels N; Rabijns A; Declerck PJ
Biochem Biophys Res Commun; 2004 Aug; 321(3):746-51. PubMed ID: 15358169
[TBL] [Abstract][Full Text] [Related]
14. Efficacious and orally bioavailable thrombin inhibitors based on a 2,5-thienylamidine at the P1 position: discovery of N-carboxymethyl-d-diphenylalanyl-l-prolyl[(5-amidino-2-thienyl)methyl]amide.
Lee K; Park CW; Jung WH; Park HD; Lee SH; Chung KH; Park SK; Kwon OH; Kang M; Park DH; Lee SK; Kim EE; Yoon SK; Kim A
J Med Chem; 2003 Aug; 46(17):3612-22. PubMed ID: 12904065
[TBL] [Abstract][Full Text] [Related]
15. Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex.
Parlow JJ; Case BL; Dice TA; Fenton RL; Hayes MJ; Jones DE; Neumann WL; Wood RS; Lachance RM; Girard TJ; Nicholson NS; Clare M; Stegeman RA; Stevens AM; Stallings WC; Kurumbail RG; South MS
J Med Chem; 2003 Sep; 46(19):4050-62. PubMed ID: 12954058
[TBL] [Abstract][Full Text] [Related]
16. Tetrahydroquinoline derivatives as potent and selective factor XIa inhibitors.
Quan ML; Wong PC; Wang C; Woerner F; Smallheer JM; Barbera FA; Bozarth JM; Brown RL; Harpel MR; Luettgen JM; Morin PE; Peterson T; Ramamurthy V; Rendina AR; Rossi KA; Watson CA; Wei A; Zhang G; Seiffert D; Wexler RR
J Med Chem; 2014 Feb; 57(3):955-69. PubMed ID: 24405333
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a low molecular weight modulator of human plasminogen activator inhibitor-1 activity.
Charlton PA; Faint RW; Bent F; Bryans J; Chicarelli-Robinson I; Mackie I; Machin S; Bevan P
Thromb Haemost; 1996 May; 75(5):808-15. PubMed ID: 8725728
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 1-[3-(aminomethyl)phenyl]-N-3-fluoro-2'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor Xa.
Pinto DJ; Orwat MJ; Wang S; Fevig JM; Quan ML; Amparo E; Cacciola J; Rossi KA; Alexander RS; Smallwood AM; Luettgen JM; Liang L; Aungst BJ; Wright MR; Knabb RM; Wong PC; Wexler RR; Lam PY
J Med Chem; 2001 Feb; 44(4):566-78. PubMed ID: 11170646
[TBL] [Abstract][Full Text] [Related]
19. Secondary structure peptide mimetics: design, synthesis, and evaluation of beta-strand mimetic thrombin inhibitors.
Boatman PD; Ogbu CO; Eguchi M; Kim HO; Nakanishi H; Cao B; Shea JP; Kahn M
J Med Chem; 1999 Apr; 42(8):1367-75. PubMed ID: 10212122
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationships of novel selective factor Xa inhibitors with a tetrahydroisoquinoline ring.
Ueno H; Yokota K; Hoshi J; Yasue K; Hayashi M; Hase Y; Uchida I; Aisaka K; Katoh S; Cho H
J Med Chem; 2005 May; 48(10):3586-604. PubMed ID: 15887966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
